Accretion Pharmaceuticals Share Price
205.00+0.05 (+0.02%)
+219.31% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
ACCPL-STNSE
Accretion Pharmaceuticals Share Price
205.00+0.05 (+0.02%)
+219.31% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 56% |
| - | - | - | 42% |
| - | - | - | 237% |
| 41% | 41% | 41% | 29% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
ACCPL-ST
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 205 | ₹228 Cr | 23.57 | — | 9.79 | ₹10 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|
| — | — | — |
| ₹11 Cr | ₹8 Cr | ₹4 Cr |
| ₹44 Cr | ₹7 Cr | ₹1 Cr |
| ₹44 Cr | ₹7 Cr | ₹1 Cr |
| ₹55 Cr | ₹15 Cr | ₹5 Cr |
| ₹0 | ₹23 L | ₹1 Cr |
| ₹86 L | ₹94 L | ₹6 Cr |
| ₹27 L | ₹19 L | ₹14,000 |
| ₹1 Cr | ₹1 Cr | ₹7 Cr |
| — | — | — |
| ₹6 Cr | ₹8 Cr | ₹7 Cr |
| ₹3 Cr | ₹4 Cr | ₹2 Cr |
| ₹9 Cr | ₹9 Cr | ₹4 Cr |
| ₹4 Cr | ₹3 Cr | ₹2 Cr |
| ₹21 Cr | ₹23 Cr | ₹15 Cr |
| ₹77 Cr | ₹40 Cr | ₹27 Cr |
| ₹12 Cr | ₹14 Cr | ₹13 Cr |
| — | — | — |
| ₹15 Cr | ₹7 Cr | ₹5 Cr |
| ₹2 Cr | ₹100 L | ₹22 L |
| ₹13 Cr | ₹6 Cr | ₹5 Cr |
| ₹20 L | ₹0 | ₹0 |
| ₹31 L | ₹23 L | ₹0 |
| ₹0 | ₹66,000 | ₹13 L |
| ₹14 Cr | ₹6 Cr | ₹5 Cr |
| — | — | — |
| ₹28 Cr | ₹21 Cr | ₹14 Cr |
| ₹22 Cr | ₹12 Cr | ₹6 Cr |
| ₹4 Cr | ₹5 L | ₹9 L |
| ₹2 L | ₹2 L | ₹6 L |
| ₹6 Cr | ₹1 Cr | ₹2 Cr |
| ₹60 Cr | ₹33 Cr | ₹22 Cr |
| ₹40 Cr | ₹10 Cr | ₹7 Cr |
| ₹3 Cr | ₹10 L | ₹0 |
| ₹77 Cr | ₹40 Cr | ₹27 Cr |
| ₹47 | ₹19 | ₹14 |
| ₹47 | ₹19 | ₹7 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|
| ₹13 Cr | ₹10 Cr | ₹2 Cr |
| ₹2 Cr | ₹2 Cr | ₹62 L |
| -₹26 Cr | -₹10 Cr | -₹15 Cr |
| -₹11 Cr | ₹2 Cr | -₹12 Cr |
| -₹15 Cr | -₹62 L | -₹12 Cr |
| -₹9 Cr | -₹2 Cr | -₹5 Cr |
| ₹27 Cr | ₹2 Cr | ₹17 Cr |
| ₹4 Cr | -₹4 L | ₹9 L |
| ₹5 L | ₹9 L | ₹0 |
| ₹4 Cr | ₹5 L | ₹9 L |
Fundamental Ratios
Consolidated
Standalone
Accretion Pharmaceuticals Share Price
205.00+0.05 (+0.02%)
+219.31% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 0 out of 9 oscillators
RSI
51.86Neutral
STOCH %K
34.58Neutral
MACD Level(12,26)
4.98Buy
Ultimate Oscillator
60.26Buy
Aroon Oscillator
86.00Buy
BOP
0.00Neutral
CCI
-48.50Neutral
Williams %R
-65.42Neutral
Momentum
3.00Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 moving averages
EMA 9
208.52Sell
SMA 9
210.73Sell
EMA 21
205.43Sell
SMA 21
206.76Sell
EMA 50
190.85Buy
SMA 50
190.77Buy
EMA 200
135.45Buy
SMA 200
120.54Buy
WMA 20
208.85Sell
Pivot
Pivot
Classic
Resistance 5
250.85
Resistance 4
240.15
Resistance 3
229.45
Resistance 2
218.75
Resistance 1
211.85
Pivot
208.05
Support 1
201.15
Support 2
197.35
Support 3
186.65
Support 4
175.95
Support 5
165.25
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Accretion Pharmaceuticals Share Price
205.00+0.05 (+0.02%)
+219.31% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|
| 73.52% | 73.52% | 73.52% | 73.52% | 73.51% |
| 0.00% | 0.00% | 0.00% | 1.16% | 2.22% |
| 2.76% | 0.00% | 0.00% | 0.00% | 0.09% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 23.72% | 26.48% | 26.48% | 25.32% | 24.18% |
Bulk & block deals
Name
Unicorn Fund
Khushboo Nahar
Gretex Share Broking Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 29 Apr 2026 | Purchase | 68.95 L | ₹102.60 | 67.20 K | Bulk | 0.604534 | NSE |
| 18 Nov 2025 | Purchase | 74.64 L | ₹76.79 | 97.20 K | Bulk | 0.874415 | NSE |
| 21 May 2025 | Sell | 1.16 Cr | ₹82.95 | 1.40 L | Bulk | 1.263044 | NSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Accretion Pharmaceuticals Share Price
205.00+0.05 (+0.02%)
+219.31% past 1 Year
Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder
Corporate Actions
Date
Type
Details
Company details
Accretion Pharmaceuticals Share Price
205.00+0.05 (+0.02%)
+219.31% past 1 Year
Corporate filings & documents
Announcements
No announcements found
Annual reports
Concalls & investor presentations
Accretion Pharmaceuticals Share Price
205.00+0.05 (+0.02%)
+219.31% past 1 Year
News
No news found